Header graphic for print
The Healthcare Investor Insights on Issues & Trends that Impact Investments in Healthcare & Life Science Businesses

Healthcare & Life Sciences Private Equity Deal Tracker: Mederi Therapeutics Secures $18.5 Million in Funding

Posted in Healthcare Services Investing

Mederi Therapeutics Inc. has announced it has secured $18.5 million in funding comprised of Series B preferred stock and venture debt.

Mederi Therapeutics, based in Greenwich, Conn., manufactures and markets medical devices that deliver radiofrequency energy to treat disease.

Participants in the funding round included venture capital firm Acadia Woods Partners, LLC, and Respiratory Diagnostics Inc. (a subsidiary of Bio-Rad Laboratories, Inc.).

Mederi indicated that the funds will be used to support and expand on the use of Mederi’s Stretta therapy for GERD and Secca therapy for bowel incontinence.

We use cookies to enhance your experience of our website. By continuing to use this website, you agree to the use of these cookies. For more information and to learn how you can change your cookie settings, please see our policy.